Avasimibe - HY-13215
Nur noch %1 verfügbar
Catalog #
HY-13215
Ab
36,00 €
Avasimibe (CI-1011; PD-148515) is an orally active acyl coenzyme A-cholesterol acyltransferase (ACAT; also called SOAT)) inhibitor with IC50s of 24 and 9.2 µM for ACAT1 and ACAT2, respectively[1]. Avasimibe can be used for the research of prostate cancer[2].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-13215/Avasimibe-DataSheet-MedChemExpress.pdf |
|---|---|
| Shipping | Room Temperature |
| Application | Cancer-programmed cell death |
| Alternative Names | CI-1011; PD-148515 |
| CAS | 166518-60-1 |
| Storage | -20°C, 3 years; 4°C, 2 years (Powder) |
| MWT | 501.72 |
| Solubility | DMSO : 100 mg/mL (ultrasonic) |
| Clinical Information | Phase 3 |
| Target | Acyltransferase |
| Application: | Cancer-programmed cell death |
|---|